Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Darifenacin Hydrobromide

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,535Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Polygen Pharmaceuticals Generic Darifenacin Hydrobromide Receives Approval In US
    Polygen Pharmaceuticals Generic Darifenacin Hydrobromide Receives Approval In US

    06 Jan 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211045

    FDA
    06 Jan 2020
    Share Share
    Alan Lab Generic Darifenacin Hydrobromide Receives Approval In US
    Alan Lab Generic Darifenacin Hydrobromide Receives Approval In US

    25 Oct 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209571

    FDA
    25 Oct 2019
    Share Share
    Alembic Pharm’s Generic Darifenacin Hydrobromide Receives Approval In US
    Alembic Pharm’s Generic Darifenacin Hydrobromide Receives Approval In US

    13 Dec 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207681

    FDA
    13 Dec 2017
    Share Share
    Alembic Pharmaceuticals gets USFDA go-ahead for bladder drug
    Alembic Pharmaceuticals gets USFDA go-ahead for bladder drug

    12 Dec 2017

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharmaceuticals-gets-usfda-go-ahead-for-bladder-drug/articleshow/62033929.cms

    ECONOMIC TIMES
    12 Dec 2017
    Share Share
    GSK achieves approval for Nucala (mepolizumab) for the treatment of (EGPA)
    GSK achieves approval for Nucala (mepolizumab) for the treatment of (EGPA)

    12 Dec 2017

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gsk-achieves-approval-for-nucala-mepolizumab-for-the-treatment-of-eosinophilic-granulomatosis-with-polyangiitis-egpa-for-adults-in-the-us-300570186.html

    PR NEWSWIRE
    12 Dec 2017
    Share Share
    Macleods Pharm’s Generic Darifenacin Hydrobromide Receives Approval In US
    Macleods Pharm’s Generic Darifenacin Hydrobromide Receives Approval In US

    31 Jul 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207302

    FDA
    31 Jul 2017
    Share Share